下一个

自动播放

Dr. Jonathan Trent on FDA Approval of Trabectedin for Soft Tissue Sarcomas

14 意见 • 07/18/23
分享
嵌入
administrator
administrator
订户
0

Jonathan C. Trent, MD, professor of Medicine, co-director, Musculoskeletal Center, Sarcoma Medical Research Program, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, discusses the FDA approval of trabectedin for patients with soft tissue sarcomas.

显示更多
0 注释 sort 排序方式
脸书评论

下一个

自动播放